G
Gonçalo S Duarte
Researcher at University of Lisbon
Publications - 65
Citations - 1214
Gonçalo S Duarte is an academic researcher from University of Lisbon. The author has contributed to research in topics: Randomized controlled trial & Meta-analysis. The author has an hindex of 14, co-authored 59 publications receiving 776 citations. Previous affiliations of Gonçalo S Duarte include Cochrane Collaboration & Instituto de Medicina Molecular.
Papers
More filters
Journal ArticleDOI
Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews
Ricardo M. Fernandes,Maria Cary,Gonçalo S Duarte,G. Jesus,J. Alarcão,Carla Torre,Suzete Costa,João Costa,António Vaz Carneiro +8 more
TL;DR: It is found that NSP was effective in reducing HIV transmission and IRB among PWID, while there were mixed results regarding a reduction of HCV infection.
Journal ArticleDOI
Botulinum toxin type A therapy for cervical dystonia
Mafalda Castelão,Raquel Esteves Marques,Gonçalo S Duarte,Filipe B. Rodrigues,Joaquim J. Ferreira,Cristina Sampaio,Austen P Moore,João Costa +7 more
TL;DR: BtA was associated with a moderate-to-large improvement in the participant's baseline clinical status as assessed by investigators, with reduction of 8.06 points in the Toronto Western Spasmodic Torticollis Rating Scale at week 4 after injection.
Journal ArticleDOI
Botulinum toxin type B for cervical dystonia.
Raquel Esteves Marques,Gonçalo S Duarte,Filipe B. Rodrigues,Mafalda Castelão,Joaquim J. Ferreira,Cristina Sampaio,A. Peter Moore,João Costa +7 more
TL;DR: Two independent authors assessed records, selected included studies, extracted data using a paper pro forma and evaluated the risk of bias, and concluded that a single BtB-treatment session is associated with a significant and clinically relevant reduction of cervical dystonia.
Journal ArticleDOI
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia
Gonçalo S Duarte,Mafalda Castelão,Filipe B. Rodrigues,Raquel Esteves Marques,Joaquim J. Ferreira,Cristina Sampaio,Austen P Moore,João Costa +7 more
TL;DR: It is currently not possible to make definitive comparisons between BtA and BtB for the treatment of cervical dystonia; uncontrolled comparisons should be regarded with suspicion.
Journal ArticleDOI
Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis.
Rui Marques,Gonçalo S Duarte,Carmelo Sterrantino,Helena Luna Pais,Antonio de Carvalho Quintela,Ana Paula Martins,João Costa +6 more
TL;DR: Moderate quality evidence suggests that first-line FOLFOXIRI provides clinically meaningful efficacy benefits in this setting, at the expense of increased toxicity.